Pathological Alterations in Lung and Liver of Male Mice Intoxicated with Benzo[a]pyrene: A time Dependent Study

Document Type : Original Article

Authors

1 Department of Pathology, Animal Health Research Institute, Dokki, Giza

2 Pathology Department, Animal Health Research Institute (AHRI), Dokki, Giza, Egypt.

3 Pathology Department, Dean of Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.

Abstract

This study aimed to investigate the pathological changes occurring in lungs and liver of male mice exposed to different doses of Benzo[a]pyrene (B[a]P) over varying durations. B[a]P is a potent carcinogenic polycyclic aromatic hydrocarbon commonly found in the environment, primarily adsorbed to particulate matter. Ninety mature mice were divided into three groups: a control negative group, a group injected with a single dose of 50 mg/kg bw of B[a] P, and a group injected with a single dose of 100 mg/kg bw of B[a] P. The experiment was conducted over several months, with ten mice from each group being sacrificed at 3, 6, and 9 months. Serum samples were collected for biochemical tests to assess liver function and tumor marker alpha-fetoprotein levels. Additionally, postmortem examinations were performed; lung and liver tissue specimens were collected for histopathological analysis. The results of the biochemical tests revealed a significant increase in Alanine aminotransferase (ALT), Aspartate aminotransferase (AST) and alpha-fetoprotein levels. Histopathological examination of the lung tissues showed a gradual initiation of mild hyperplastic proliferation in the bronchiolar epithelia at both half (50 mg/kg bw) and full (100 mg/kg bw) doses of B[a] P, with more pronounced changes observed in the full-dose groups at 6 and 9 months. At 9 months of full-dose treatment, a well-defined circumscribed tumor mass was detected. In the liver, cellular changes were observed at 3 months for both half and full doses of B[a]P, progressing to malignant changes at 6 months and ultimately leading to the development of hepatocellular adenocarcinoma at 9 months.

Keywords

Main Subjects



Articles in Press, Corrected Proof
Available Online from 18 August 2024
  • Receive Date: 07 March 2024
  • Revise Date: 11 August 2024
  • Accept Date: 12 August 2024